Alba Luengo

Alba Luengo

Auto-generated profile, based on publicly available information

Alba Luengo

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Cell Chemical Biology
Verified
Journal Article
Closed access
ALAlba Luengo
Alba Luengo
DGDan Y. Gui
Dan Y. Gui
MHMatthew G. Vander Heiden
Matthew G. Vander Heiden

1 March 2016 in Cell Metabolism
Verified
Journal Article
Closed access
SDShawn M. Davidson
Shawn M. Davidson
TPThales Papagiannakopoulos
Thales Papagiannakopoulos
BOBenjamin A. Olenchock
Benjamin A. Olenchock
JHJulia E. Heyman
Julia E. Heyman
MKMark A. Keibler
Mark A. Keibler
MHMatthew G. Vander Heiden
Matthew G. Vander Heiden

1 February 2021 in Molecular Cell
Verified
Journal Article
Open access
ALAlba Luengo
Alba Luengo
ZLZhaoqi Li
Zhaoqi Li
DGDan Y. Gui
Dan Y. Gui
LSLucas Sullivan
Lucas Sullivan
MZMaria Zagorulya
Maria Zagorulya
MHMatthew G. Vander Heiden
Matthew G. Vander Heiden
Aerobic glycolysis, or preferential fermentation of glucose-derived pyruvate to lactate despite available oxygen, is associated with proliferation across many organisms and conditions. To better understand that association, we examined the metabolic consequence of activating the pyruvate dehydrogenase complex (PDH) to increase pyruvate oxidation at the expense of fermentation. We find that increasing PDH activity impairs cell proliferation by reducing the NAD+/NADH ratio. This change in NAD+/NADH is caused by increased mitochondrial membrane potential that impairs mitochondrial electron transport and NAD+ regeneration. Uncoupling respiration from ATP synthesis or increasing ATP hydrolysis restores NAD+/NADH homeostasis and proliferation even when glucose oxidation is increased. These data suggest that when demand for NAD+ to support oxidation reactions exceeds the rate of ATP turnover in cells, NAD+ regeneration by mitochondrial respiration becomes constrained, promoting fermentation, despite available oxygen. This argues that cells engage in aerobic glycolysis when the demand for NAD+ is in excess of the demand for ATP.

25 April 2016 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
MPMichael E. Pacold
Michael E. Pacold
KBKyle R Brimacombe
Kyle R Brimacombe
SCSze Ham Chan
Sze Ham Chan
JRJason M Rohde
Jason M Rohde
CLCaroline A Lewis
Caroline A Lewis
DSDavid M Sabatini
David M Sabatini
A quantitative high-throughput screen identified an inhibitor of phosphoglycerate dehydrogenase (PHGDH), a key enzyme for serine synthesis. This inhibitor limits one-carbon unit availability for nucleotide synthesis. Serine is both a proteinogenic amino acid and the source of one-carbon units essential for de novo purine and deoxythymidine synthesis. In the canonical pathway of glucose-derived serine synthesis, Homo sapiens phosphoglycerate dehydrogenase (PHGDH) catalyzes the first, rate-limiting step. Genetic loss of PHGDH is toxic toward PHGDH-overexpressing breast cancer cell lines even in the presence of exogenous serine. Here, we used a quantitative high-throughput screen to identify small-molecule PHGDH inhibitors. These compounds reduce the production of glucose-derived serine in cells and suppress the growth of PHGDH-dependent cancer cells in culture and in orthotopic xenograft tumors. Surprisingly, PHGDH inhibition reduced the incorporation into nucleotides of one-carbon units from glucose-derived and exogenous serine. We conclude that glycolytic serine synthesis coordinates the use of one-carbon units from endogenous and exogenous serine in nucleotide synthesis, and we suggest that one-carbon unit wasting thus may contribute to the efficacy of PHGDH inhibitors in vitro and in vivo.

25 June 2018 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
LSLucas Sullivan
Lucas Sullivan
ALAlba Luengo
Alba Luengo
LDLaura V. Danai
Laura V. Danai
LBLauren N. Bush
Lauren N. Bush
FDFrances F. Diehl
Frances F. Diehl
MHMatthew G. Vander Heiden
Matthew G. Vander Heiden

1 April 2021 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
GFGino B. Ferraro
Gino B. Ferraro
AAAhmed Ali
Ahmed Ali
ALAlba Luengo
Alba Luengo
DKDavid P. Kodack
David P. Kodack
ADAmy Deik
Amy Deik
MHMatthew G. Vander Heiden
Matthew G. Vander Heiden